Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OMNII Oral Pharmaceuticals
West Palm Beach, Florida, United Statesomniiproducts.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
OMNII Oral Pharmaceuticals was a specialized pharmaceutical and dental products company focused on preventive dentistry and oral health. The company was a market leader in providing professional-grade fluoride varnishes, gels, and antimicrobial rinses used by dental professionals to treat gingivitis and prevent tooth decay. Its most prominent product was Peridex (chlorhexidine gluconate 0.12%), a gold-standard prescription oral rinse for the treatment of gingivitis. In 2006, OMNII was acquired by 3M and integrated into its 3M ESPE dental division, which significantly bolstered 3M's portfolio in the preventive oral care market.
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- Small moleculeTopical formulation
- Industry
- Biotech
Beyond the preview
Go deeper on OMNII Oral Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OMNII Oral Pharmaceuticals.